ROIV logo
ROIV NASDAQ GB

Roivant Sciences Ltd. - Common Shares

Healthcare · Biotechnology Website · IPO Dec 2020
$28.33
▲ +$0.49 (+1.76%)
Vol 5.0M
4
Quality Score
fail
Mkt Cap
$15.1B
ROE
-8.1%
Margin
-1839.6%
D/E
0.00
Beta
1.23
52W
$9–$23

Wall Street Consensus

19 analysts · Apr 2026
8
Strong Buy
9
Buy
2
Hold
0
Sell
0
Strong Sell
89.5%
Buy Rating

Price Chart

Similar Stocks

CNTA
Centessa Pharmaceuticals PLC
$3.4B
KNSA
Kiniksa Pharmaceuticals International PLC
P/E 87.0
$3.1B
IMCR
Immunocore Holdings PLC
$1.8B
CMPS
Compass Pathways PLC
$662.4M
AUTL
Autolus Therapeutics PLC
$524.3M
BCYC
Bicycle Therapeutics PLC
$471.3M

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.32 $-0.38 $-0.06
Sep 2025 $-0.34 $-0.17 +$0.17
Jun 2025 $-0.32 $-0.33 $-0.01
Mar 2025 $-0.31 $-0.29 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -10.1% -3.4% -10.1% -10.1% -8.1% -8.1%
P/E (TTM) — — — — — —
Net Margin -10292.9% -225.7% -2111.8% -2111.8% -1839.6% -1839.6%
Gross Margin 92.9% 36.9% 96.3% 96.3% 96.4% 96.4%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 40.54 33.47 40.54 40.54 33.70 33.70

Key Ratios

ROA (TTM)
-7.0%
P/S (TTM)
742.40
P/B
1.5
EPS (TTM)
$-0.55
CF/Share
$-1.62
Rev Growth 3Y
-19.3%
52W High
$23.47
52W Low
$8.73
$8.73 52-Week Range $23.47

How does ROIV compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ROIV AAPG ABEO ABOS ABP

ROIV valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
742.4
▲ 5677% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.5
▼ 38% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ROIV profitability vs Biotechnology peers

ROE
-8.1%
▲ 88% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-1839.6%
▼ 542% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
96.4%
▲ 23% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-7.0%
▲ 85% above peers (-46.7%)
vs Peers
vs Industry
Top tier

ROIV financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
33.7
▲ 659% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲ 26% above peers (1.0)
vs Peers
vs Industry
More volatile

ROIV fundamentals radar

ROIV Peer median Industry

ROIV profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ROIV vs peers: key metrics

Latest News

Bernstein Initiates Coverage of Roivant Sciences Ltd. (ROIV) with an Outperform Rating
Yahoo Finance · Mar 25